Alerts will be sent to your verified email
Verify Email
DIVISLAB
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Divi's Laboratories Limited is a global pharmaceutical company specializing in the manufacturing of API's, Intermediates, and Nutraceutical ingredients for exports. It also offers custom synthesis services to innovator pharma companies for their patented products.
Divi's Lab major competitors are Laurus Labs, Neuland Laboratories, Alivus Life Sciences, Granules India, AMI Organics, Aarti Pharmalabs, Shilpa Medicare.
Market Cap of Divi's Lab is ₹1,49,680 Crs.
While the median market cap of its peers are ₹11,336 Crs.
Divi's Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun | Jun Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
